Gyeonggi-do, South Korea

Ki-Weon Seo

USPTO Granted Patents = 1 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ki-Weon Seo: Innovator in Vaccine Development

Introduction

Ki-Weon Seo is a prominent inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of vaccine development through his innovative research and patents. His work focuses on cell lines that can be used for the production of vaccines, which is crucial for public health.

Latest Patents

Ki-Weon Seo holds a patent for a Vero cell line that can be suspension-cultured in serum-free medium. The patent is titled "Vero cell line that can be suspension-cultured in serum-free medium, preparation method therefor, and method for preparing viruses for vaccines by using novel cell line." This invention relates to sVERO 7C2, a Vero cell line derived from the African Green Monkey Kidney Cell Line distributed by the WHO. The cell line is capable of suspension culture without serum components, which is a significant advancement in the field. The patent also includes a culture method for growing the Vero cells and a method for producing a vaccine virus using these cells. Ki-Weon Seo has 1 patent to his name.

Career Highlights

Ki-Weon Seo is currently associated with SK Bioscience Co., Ltd., a company known for its focus on vaccine development and biotechnology. His work at the company has been instrumental in advancing vaccine technologies and improving public health outcomes.

Collaborations

Ki-Weon Seo has collaborated with notable colleagues, including Jun-seok Kwak and Eun-Som Kim. These collaborations have further enhanced the research and development efforts in the field of vaccine production.

Conclusion

Ki-Weon Seo is a key figure in the innovation of vaccine development, with a focus on improving cell culture methods for vaccine production. His contributions are vital for advancing public health initiatives and ensuring the availability of effective vaccines.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…